-
公开(公告)号:US20180194849A1
公开(公告)日:2018-07-12
申请号:US15538419
申请日:2016-01-08
Applicant: BIONTECH AG , GENMAB A/S
Inventor: Ugur Sahin , Friederike Gieseke , Isil Altintas , David Satijn , Paul Parren
IPC: C07K16/28
Abstract: The present invention relates to binding agents binding to receptors of the TNF superfamily, in particular binding agents binding to at least two different receptors of the TNF superfamily, as well as to their use in medicine. The present invention further relates to nucleic acid molecules encoding such binding agents, to cells comprising such nucleic acid molecules and to pharmaceutical compositions and kits.
-
公开(公告)号:US10457735B2
公开(公告)日:2019-10-29
申请号:US15538419
申请日:2016-01-08
Applicant: BIONTECH AG , GENMAB A/S
Inventor: Ugur Sahin , Friederike Gieseke , Isil Altintas , David Satijn , Paul Parren
IPC: C07K16/28
Abstract: The present invention relates to binding agents binding to receptors of the TNF superfamily, in particular binding agents binding to at least two different receptors of the TNF superfamily, as well as to their use in medicine. The present invention further relates to nucleic acid molecules encoding such binding agents, to cells comprising such nucleic acid molecules and to pharmaceutical compositions and kits.
-
公开(公告)号:US20240376221A1
公开(公告)日:2024-11-14
申请号:US18660672
申请日:2024-05-10
Applicant: Genmab A/S , BioNTech SE
Inventor: Kristel Kemper , Maarten van der Kroef , Dennis Verzijl , Andrea Gorlani , Pauline Linda de Goeje , Lars Guelen , David Satijn , Esther C. W. Breij , Ugur Sahin , Sina Fellermeier-Kopf , Maren Köhne
Abstract: The present invention relates to antibodies capable of binding to human OX40 and to variants thereof comprising a modified Fc region comprising at least one mutation that enhances the Fc-Fc interaction of the antibody and at least one mutation that reduces the Fc effector functions of the antibody. The invention further provides pharmaceutical compositions comprising the antibodies and use of the antibodies for therapeutic and diagnostic procedures, in particular in cancer therapy.
-
公开(公告)号:US12077596B2
公开(公告)日:2024-09-03
申请号:US17360438
申请日:2021-06-28
Applicant: GENMAB A/S , BioNTech SE
Inventor: Isil Altintas , David Satijn , Rik Rademaker , Paul Parren , Friederike Gieseke , Ugur Sahin
IPC: C07K16/28 , A61K39/395 , G01N33/569
CPC classification number: C07K16/2878 , A61K39/3955 , G01N33/56972 , C07K2317/24 , C07K2317/31 , C07K2317/524 , C07K2317/526 , C07K2317/53 , C07K2317/565 , C07K2317/92
Abstract: Multispecific antibodies binding to human CD40 and human CD137, methods for preparing such multispecific antibodies, and methods of using such multispecific antibodies for therapeutic or other purposes.
-
公开(公告)号:US11939388B2
公开(公告)日:2024-03-26
申请号:US17360437
申请日:2021-06-28
Applicant: GENMAB A/S , BioNTech SE
Inventor: Isil Altintas , David Satijn , Rik Rademaker , Paul Parren , Friederike Gieseke , Ugur Sahin
IPC: C07K16/28 , A61K39/395 , G01N33/569
CPC classification number: C07K16/2878 , A61K39/3955 , G01N33/56972 , C07K2317/24 , C07K2317/31 , C07K2317/524 , C07K2317/526 , C07K2317/53 , C07K2317/565 , C07K2317/92
Abstract: Multispecific antibodies binding to human CD40 and human CD137, methods for preparing such multispecific antibodies, and methods of using such multispecific antibodies for therapeutic or other purposes.
-
公开(公告)号:US11440966B2
公开(公告)日:2022-09-13
申请号:US17345628
申请日:2021-06-11
Applicant: GENMAB A/S , BioNTech SE
Inventor: Isil Altintas , David Satijn , Rik Rademaker , Paul Parren , Friederike Gieseke , Ugur Sahin
IPC: C07K16/28 , A61K39/395 , G01N33/569
Abstract: Multispecific antibodies binding to human CD40 and human CD137, methods for preparing such multispecific antibodies, and methods of using such multispecific antibodies for therapeutic or other purposes.
-
公开(公告)号:US11091557B2
公开(公告)日:2021-08-17
申请号:US16316534
申请日:2017-07-14
Applicant: GENMAB A/S , BioNTech SE
Inventor: Isil Altintas , David Satijn , Rik Rademaker , Paul Parren , Friederike Gieseke , Ugur Sahin
IPC: A61K39/395 , C07K16/28 , G01N33/569
Abstract: Multispecific antibodies binding to human CD40 and human CD137, methods for preparing such multispecific antibodies, and methods of using such multispecific antibodies for therapeutic or other purposes.
-
公开(公告)号:US10927181B2
公开(公告)日:2021-02-23
申请号:US16582534
申请日:2019-09-25
Applicant: BIONTECH SE , GENMAB A/S
Inventor: Ugur Sahin , Friederike Gieseke , Isil Altintas , David Satijn , Paul Parren
IPC: C07K16/28
Abstract: The present invention relates to binding agents binding to receptors of the TNF superfamily, in particular binding agents binding to at least two different receptors of the TNF superfamily, as well as to their use in medicine. The present invention further relates to nucleic acid molecules encoding such binding agents, to cells comprising such nucleic acid molecules and to pharmaceutical compositions and kits.
-
公开(公告)号:US11084882B2
公开(公告)日:2021-08-10
申请号:US16855703
申请日:2020-04-22
Applicant: GENMAB A/S , BioNTech SE
Inventor: Isil Altintas , David Satijn , Rik Rademaker , Paul Parren , Friederike Gieseke , Ugur Sahin
IPC: C07K16/28 , A61K39/395 , G01N33/569
Abstract: Multispecific antibodies binding to human CD40 and human CD137, methods for preparing such multispecific antibodies, and methods of using such multispecific antibodies for therapeutic or other purposes.
-
公开(公告)号:US11814411B2
公开(公告)日:2023-11-14
申请号:US17144591
申请日:2021-01-08
Applicant: BIONTECH SE , GENMAB A/S
Inventor: Ugur Sahin , Friederike Gieseke , Isil Altintas , David Satijn , Paul Parren
IPC: C07K16/28
CPC classification number: C07K16/2878 , C07K2317/31 , C07K2317/565 , C07K2317/75 , C07K2317/92
Abstract: The present invention relates to binding agents binding to receptors of the TNF superfamily, in particular binding agents binding to at least two different receptors of the TNF superfamily, as well as to their use in medicine. The present invention further relates to nucleic acid molecules encoding such binding agents, to cells comprising such nucleic acid molecules and to pharmaceutical compositions and kits.
-
-
-
-
-
-
-
-
-